<DOC>
	<DOCNO>NCT02261467</DOCNO>
	<brief_summary>This safety efficacy study onabotulinumtoxinA subject forehead glabellar facial rhytides ( frown line ) .</brief_summary>
	<brief_title>A Safety Efficacy Study OnabotulinumtoxinA Forehead Glabellar Facial Rhytides</brief_title>
	<detailed_description />
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Moderate severe forehead glabellar line Willing facial photo take Prior exposure botulinum toxin serotype indication Anticipated need treatment botulinum toxin serotype indication study , study treatment Diagnosis myasthenia gravis , EatonLambert syndrome , amyotrophic lateral sclerosis Any facial resurfacing laser light treatment , microdermabrasion , superficial peel past 3 month Any medium depth deep depth facial chemical peel ; facial skin resurfacing ; permanent facial makeup past 6 month Any nonpermanent soft tissue filler , treatment oral retinoids past year Prior face lift , thread lift , eyebrow lift , related procedure ( eg , eyelid and/or eyebrow surgery ) Prior facial treatment permanent soft tissue filler , synthetic implant ( eg , GoreTexÂ® ) , and/or fat transplantation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>